SPBC660.15 Antibody

Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped proteins composed of two heavy chains and two light chains (κ or λ) connected by disulfide bonds. Their structure includes:

• Fab fragment: Binds antigens via variable domains (paratope).

• Fc region: Mediates biological effector functions (e.g., complement activation, Fc receptor binding) .

Antibody Development and Engineering

Modern antibody development often involves synthetic libraries or phage display, as seen in the generation of high-affinity antibodies like 1-15D1 (targeting Siglec-15) or DISC0280 (anti-IL-15) . Key steps include:

• Library diversification: Randomization of complementarity-determining regions (CDRs) to enhance binding diversity .

• Affinity maturation: Mutagenesis and selection for improved binding .

Functional Validation

Antibodies are rigorously tested for specificity and efficacy:

• Neutralization assays: Measure inhibition of target activity (e.g., IL-15-dependent cell proliferation) .

• Flow cytometry: Detects surface antigen binding (e.g., CD363/S1PR1) .

• Immunoprecipitation: Confirms target binding in complex samples .

Therapeutic Applications

Antibodies like 1-15D1 and DISC0280 demonstrate therapeutic potential by:

• Blocking immune checkpoints: Enhancing T-cell responses (Siglec-15) .

• Modulating cytokine signaling: Reducing inflammation (IL-15) .